176 related articles for article (PubMed ID: 23891982)
1. Increased plasticity of the stiffness of melanoma cells correlates with their acquisition of metastatic properties.
Weder G; Hendriks-Balk MC; Smajda R; Rimoldi D; Liley M; Heinzelmann H; Meister A; Mariotti A
Nanomedicine; 2014 Jan; 10(1):141-8. PubMed ID: 23891982
[TBL] [Abstract][Full Text] [Related]
2. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH
Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039
[TBL] [Abstract][Full Text] [Related]
4. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
Hussein MR; Elsers DA; Fadel SA; Omar AE
J Clin Pathol; 2006 Mar; 59(3):316-24. PubMed ID: 16505286
[TBL] [Abstract][Full Text] [Related]
5. AJCC 8th Edition (2017) versus AJCC 7th Edition (2010) in thin melanoma staging.
Roncati L; Piscioli F
Neoplasma; 2018 Sep; 65(5):651-655. PubMed ID: 30249100
[TBL] [Abstract][Full Text] [Related]
6. Biophysical and Biochemical Characteristics as Complementary Indicators of Melanoma Progression.
Bobrowska J; Awsiuk K; Pabijan J; Bobrowski P; Lekki J; Sowa KM; Rysz J; Budkowski A; Lekka M
Anal Chem; 2019 Aug; 91(15):9885-9892. PubMed ID: 31310097
[TBL] [Abstract][Full Text] [Related]
7. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions.
Mills CN; Joshi SS; Niles RM
Mol Cancer; 2009 Nov; 8():104. PubMed ID: 19919690
[TBL] [Abstract][Full Text] [Related]
9. AFM and QCM-D as tools for the distinction of melanoma cells with a different metastatic potential.
Sobiepanek A; Milner-Krawczyk M; Lekka M; Kobiela T
Biosens Bioelectron; 2017 Jul; 93():274-281. PubMed ID: 27591901
[TBL] [Abstract][Full Text] [Related]
10. A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.
Blackburn JS; Liu I; Coon CI; Brinckerhoff CE
Oncogene; 2009 Dec; 28(48):4237-48. PubMed ID: 19734937
[TBL] [Abstract][Full Text] [Related]
11. Cytoskeletal tubulin competes with actin to increase deformability of metastatic melanoma cells.
Higgins G; Peres J; Abdalrahman T; Zaman MH; Lang DM; Prince S; Franz T
Exp Cell Res; 2020 Sep; 394(2):112154. PubMed ID: 32598874
[TBL] [Abstract][Full Text] [Related]
12. Problems in the interpretation of apparent "radial growth phase" malignant melanomas that metastasize.
Abramova L; Slingluff CL; Patterson JW
J Cutan Pathol; 2002 Aug; 29(7):407-14. PubMed ID: 12139635
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma.
Magnoni C; Tenedini E; Ferrari F; Benassi L; Bernardi C; Gualdi G; Bertazzoni G; Roncaglia E; Fantoni L; Manfredini R; Bicciato S; Ferrari S; Giannetti A; Tagliafico E
Br J Dermatol; 2007 Jan; 156(1):62-71. PubMed ID: 17199568
[TBL] [Abstract][Full Text] [Related]
14. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group.
Cook MG; Spatz A; Bröcker EB; Ruiter DJ
J Pathol; 2002 Jun; 197(2):188-93. PubMed ID: 12015742
[TBL] [Abstract][Full Text] [Related]
15. Microrheological comparison of melanoma cells by atomic force microscopy.
Brás MM; Sousa A; Cruz TB; Michalewski J; Leite M; Sousa SR; Granja PL; Radmacher M
J Biol Phys; 2024 Mar; 50(1):55-69. PubMed ID: 38240860
[TBL] [Abstract][Full Text] [Related]
16. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
17. Regulation of pigmentation by substrate elasticity in normal human melanocytes and melanotic MNT1 human melanoma cells.
Choi H; Kim M; Ahn SI; Cho EG; Lee TR; Shin JH
Exp Dermatol; 2014 Mar; 23(3):172-7. PubMed ID: 24517137
[TBL] [Abstract][Full Text] [Related]
18. Epidermotropically metastatic malignant melanoma. Differentiating malignant melanoma metastatic to the epidermis from malignant melanoma primary in the epidermis.
Kornberg R; Harris M; Ackerman AB
Arch Dermatol; 1978 Jan; 114(1):67-9. PubMed ID: 619785
[TBL] [Abstract][Full Text] [Related]
19. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
